Web News Insider
-
NIH says All of Us is now the world’s largest integrated health database
NEW YORK, July 1 — 747,000 participants. That is the headline number for the National Institutes of Health’s All of Us research…
-
NIH expands All of Us data set as program funding falls 71% from 2023 levels
The UK Biobank had a problem. It was big — roughly 500,000 participants with genomes and health records. But it was also…
-
Glasgow Ebola Test Negative as Congo Outbreak Rages On
GLASGOW, July 1 — A patient admitted to Glasgow’s Queen Elizabeth University Hospital has tested negative for Ebola, ending a brief lockdown.…
-
New Analyses Link Mogamulizumab to Longer Survival in Two Rare Skin Lymphomas
PRINCETON, N.J., June 30 — New analyses are helping doctors better understand the long-term survival picture for patients with two rare forms…
-
Diabetic man falls into coma as Siberian ambulance has no fuel amid Russian shortages
A diabetic man slipped into a coma. His wife called for an ambulance. The dispatcher told her to find her own ride.…
-
Spanish Researcher Builds CAR-T Cells Against Rare Childhood Rhabdoid Tumours
A single gene gone wrong. That is the core problem with rhabdoid tumours. And it is the core clue that a Spanish…
-
Germany’s Lack of Heat Protection Rules Endangers Nursing Homes
A national policy gap is now impossible to ignore in Germany. The country has no federal heat protection regulations requiring cooling systems…
-
QIMR Berghofer study: 70% of Queenslanders used skin cancer services in eight years
For decades, Queensland has been the place where the sun doesn’t just shine — it attacks. The state holds the world’s highest…
-
Zelluna Secures NOK 16 Million Grant for TCR-NK Research
OSLO, June 30 — Zelluna ASA, a company listed on the Oslo Stock Exchange under the ticker ZLNA, has been awarded a…
-
Omega-3 health update after major new study into claims
LOS ANGELES, June 30 — 365 older adults. Two years. Zero measurable brain benefit from fish oil supplements. That is the bottom…
-
High-Dose Fish Oil Shows No Cognitive Benefit in Older Adults at Alzheimer’s Risk
LOS ANGELES — For two years, researchers tracked 365 older adults who took high doses of fish oil. The result, published by…
-
USC study finds fish oil reaches brain but fails to boost cognition in older adults
LOS ANGELES — The omega-3s got to the brain. They just didn’t do anything once they got there. That is the finding…
-
Quick-Delivery Apps Approve Prescription Medicines With a Brief Call, Doctors Warn
MANILA, June 30 — For many Filipino families, getting a prescription refilled can be a hassle. But a recent experience by Ratish…
-
Buckie trainee ambulance technician, in remission from rare lymphoma, launches Aberdeen Race for Life
ABERDEEN — Dr. Gavin Preston delivered the news on June 22 last year. He told Kayla Esson the cancer was gone. For…
-
Young cancer survivor Kayla Esson starts Aberdeen Race for Life a year after remission
She went from patient to starter. Kayla Esson, 22, stood at the front of 1,100 runners in Aberdeen on Sunday and blew…
-
Cancer cells feed on glutathione, a popular supplement, Rochester researchers find
NEW YORK, June 30 — If TikTok is to be believed, the fastest way to reduce inflammation, improve immunity, increase energy and…
-
USC scientists unlock endless supply of cancer-fighting immune cells
LOS ANGELES, June 29 — Scientists at USC Stem Cell have developed a new method for creating a renewable and expandable supply…
-
Multilevel training model to speed child cancer diagnosis in Ethiopia
ADDIS ABABA — A new training and mentorship model is showing early promise in accelerating the diagnosis of childhood cancer in Northwest…
-
Anixa Biosciences Gets First Korean Patent for Breast Cancer Vaccine
SAN JOSE, June 29 — Anixa Biosciences has secured its first Korean patent for a breast cancer vaccine, a move that extends…
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
A third of people with cancer red-flag symptoms did not see a GP for six months
LONDON — A troubling new picture of how Brits respond to possible cancer symptoms has emerged, with research showing that a third…
-
Cancer signs thousands overlook – ‘won’t contact GP for
LONDON, June 29 — A troubling pattern is emerging across the UK, one that families here and across Asia might recognise all…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
USF researchers find Antarctic sea squirt compound kills melanoma in mice
TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times. And one compound that killed melanoma in mice…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992